Annals of Surgical Oncology

, Volume 12, Issue 4, pp 282–288 | Cite as

A Nomogram That Predicts the Presence of Sentinel Node Metastasis in Melanoma With Better Discrimination Than the American Joint Committee on CancerStaging System

  • Sandra L. Wong
  • Michael W. Kattan
  • Kelly M. McMasters
  • Daniel G. Coit



The threshold and indications for sentinel lymph node (SLN) biopsy in patients with melanoma remain somewhat arbitrary. Many variables associated with SLN positivity have previously been identified, including a significant association between the American Joint Committee on Cancer (AJCC) staging system and SLN status. We developed a user-friendly nomogram that takes several characteristics into account simultaneously to more accurately predict the presence of SLN metastasis for an individual patient.


A total of 979 patients who underwent successful SLN biopsy for cutaneous melanoma at a single institution between February 1991 and November 2003 were included in the analysis. Predictors were used to develop a nomogram, based on logistic regression analysis, to predict the probability of SLN positivity. A large multi-institutional trial with 3108 patients was used to validate the predictive accuracy of the nomogram compared with the AJCC staging system.


The nomogram was developed and found to be accurate and discriminating. The concordance index of the nomogram, a measure of predictive ability, was .694 when evaluated with the validation dataset. In contrast, the concordance index of the AJCC staging system was lower (.663; P < .001).


Using commonly available clinicopathologic information, we developed a nomogram to accurately predict the probability of a positive SLN in patients with melanoma. This tool takes several characteristics into account simultaneously. This model should enable improved patient counseling and treatment selection.


Melanoma Sentinel node biopsy Nomogram Prognosis 


  1. 1.
    Jemal, A, Murray, T, Ward, E,  et al. 2005Cancer statistics, 2005 CA Cancer J Clin551030CrossRefPubMedGoogle Scholar
  2. 2.
    Gershenwald, JE, Thompson, W, Mansfield, PF,  et al. 1999Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patientsJ Clin Oncol1797683PubMedGoogle Scholar
  3. 3.
    Balch, CM, Soong, SJ, Gershenwald, JE,  et al. 2001Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin Oncol19362234PubMedGoogle Scholar
  4. 4.
    McMasters, KM, Wong, SL, Edwards, MJ,  et al. 2001Factors that predict the presence of sentinel lymph node metastasis in patients with melanomaSurgery1301516PubMedGoogle Scholar
  5. 5.
    Wagner, JD, Gordon, MS, Chuang, TY,  et al. 2000Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanomaCancer8945362PubMedGoogle Scholar
  6. 6.
    Porter, GA, Ross, MI, Berman, RS, Lee, JE, Mansfield, PF, Gershenwald, JE 2000Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsyAnn Surg Oncol725661PubMedGoogle Scholar
  7. 7.
    Balch, CM, Buzaid, AC, Soong, SJ,  et al. 2001Final version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin Oncol19363548PubMedGoogle Scholar
  8. 8.
    Rousseau, DL,Jr, Ross, MI, Johnson, MM,  et al. 2003Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patientsAnn Surg Oncol1056974PubMedGoogle Scholar
  9. 9.
    McMasters, KM, Reintgen, DS, Ross, MI,  et al. 2001Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?Ann Surg Oncol81927PubMedGoogle Scholar
  10. 10.
    DeLong, ER, DeLong, DM, Clarke-Pearson, DL 1988Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachBiometrics4483745PubMedGoogle Scholar
  11. 11.
    Morton, DL, Wen, DR, Wong, JH,  et al. 1992Technical details of intraoperative lymphatic mapping for early stage melanomaArch Surg1273929PubMedGoogle Scholar
  12. 12.
    Bleicher, RJ, Essner, R, Foshag, LJ, Wanek, LA, Morton, DL 2003Role of sentinel lymphadenectomy in thin invasive cutaneous melanomasJ Clin Oncol21132631PubMedGoogle Scholar
  13. 13.
    Jacobs, IA, Chang, CK, DasGupta, TK, Salti, GI 2003Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanomaAnn Surg Oncol1055861PubMedGoogle Scholar
  14. 14.
    Zapas, JL, Coley, HC, Beam, SL, Brown, SD, Jablonski, KA, Elias, EG 2003The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsyJ Am Coll Surg1974037PubMedGoogle Scholar
  15. 15.
    Sondak, VK, Taylor, JM, Sabel, MS,  et al. 2004Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic modelAnn Surg Oncol1124758PubMedGoogle Scholar
  16. 16.
    Begg, CB, Cramer, LD, Venkatraman, ES, Rosai, J 2000Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a modelStat Med1919972014PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2005

Authors and Affiliations

  • Sandra L. Wong
    • 1
  • Michael W. Kattan
    • 2
  • Kelly M. McMasters
    • 3
  • Daniel G. Coit
    • 1
  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew York
  2. 2.Department of Biostatistics and EpidemiologyCleveland Clinic FoundationCleveland
  3. 3.Department of Surgery, Division of Surgical OncologyUniversity of Louisville School of MedicineLouisville

Personalised recommendations